Trials / Completed
CompletedNCT04713735
Impact of Lactoferrin, a Dietary Supplement, vs. Placebo on Respiratory Tract Infections
A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Impact of Lactoferrin Dietary Supplementation on Respiratory Tract Infections in an Elderly Population
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 76 (actual)
- Sponsor
- Mead Johnson Nutrition · Industry
- Sex
- All
- Age
- 55 Years
- Healthy volunteers
- Accepted
Summary
This is a randomized, double-blind, placebo-controlled study to evaluate the impact of bovine Lactoferrin (bLf) on respiratory tract infections (RTIs) in an elderly population in the United States.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Control: Placebo | Placebo |
| DIETARY_SUPPLEMENT | bovine lactoferrin supplement | 600 mg |
Timeline
- Start date
- 2021-02-08
- Primary completion
- 2022-02-28
- Completion
- 2023-04-28
- First posted
- 2021-01-19
- Last updated
- 2023-10-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04713735. Inclusion in this directory is not an endorsement.